Department of Health and Social Care (DHSC) has issued a medicine supply notification for Atorvastatin (Lipitor®) 20mg chewable tablets.
MSN/2022/098
Tier 2 – medium impact
Date of issue 24th November 2022
Atorvastatin (Lipitor®) 20mg chewable tablets are out of stock until late December 2022.
Atorvastatin 20mg film-coated tablets and atorvastatin 20mg/5ml oral suspension remain available and can support a full uplift in demand.
Atorvastatin (Lipitor®) 10mg chewable tablets are in limited supply and cannot support an uplift in demand.
A Serious Shortage Protocol (SSP) was issued on 23/11/2022.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Atorvastatin (Lipitor® ) 20mg chewable tablets appeared first on PSNC Website.